Business Description
Hemogenyx Pharmaceuticals PLC
ISIN : GB00BYX3WZ24
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.42 | |||||
Equity-to-Asset | 0.46 | |||||
Debt-to-Equity | 1.05 | |||||
Debt-to-EBITDA | -0.51 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EPS without NRI Growth Rate | -6.3 | |||||
3-Year FCF Growth Rate | -6.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 46.63 | |||||
9-Day RSI | 43.88 | |||||
14-Day RSI | 41.62 | |||||
6-1 Month Momentum % | -31.25 | |||||
12-1 Month Momentum % | -19.51 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.33 | |||||
Quick Ratio | 3.33 | |||||
Cash Ratio | 1.91 | |||||
Days Payable | 73.35 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -39.4 | |||||
Shareholder Yield % | -24.11 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -205.71 | |||||
ROA % | -98.29 | |||||
ROIC % | -119.66 | |||||
ROC (Joel Greenblatt) % | -170.19 | |||||
ROCE % | -104.92 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 7.38 | |||||
EV-to-EBIT | -3.42 | |||||
EV-to-EBITDA | -3.81 | |||||
EV-to-FCF | -3.45 | |||||
Earnings Yield (Greenblatt) % | -29.23 | |||||
FCF Yield % | -30.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Hemogenyx Pharmaceuticals PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil £) | |||
EPS (TTM) (£) | -0.006 | ||
Beta | 1.27 | ||
Volatility % | 91.48 | ||
14-Day RSI | 41.62 | ||
14-Day ATR (£) | 0.001091 | ||
20-Day SMA (£) | 0.015327 | ||
12-1 Month Momentum % | -19.51 | ||
52-Week Range (£) | 0.011 - 0.07134 | ||
Shares Outstanding (Mil) | 1,341.82 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Hemogenyx Pharmaceuticals PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Hemogenyx Pharmaceuticals PLC Stock Events
Event | Date | Price(£) | ||
---|---|---|---|---|
No Event Data |
Hemogenyx Pharmaceuticals PLC Frequently Asked Questions
What is Hemogenyx Pharmaceuticals PLC(LSE:HEMO)'s stock price today?
When is next earnings date of Hemogenyx Pharmaceuticals PLC(LSE:HEMO)?
Does Hemogenyx Pharmaceuticals PLC(LSE:HEMO) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |